APA-referens

Parvin, S., Ramirez-Labrada, A., Aumann, S., Lu, X., Weich, N., Santiago, G., . . . Lossos, I. S. (2019). LMO2 confers synthetic lethality to PARP inhibition in DLBCL. Cancer Cell.

Chicago-stil citat

Parvin, Salma, et al. "LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL." Cancer Cell 2019.

MLA-referens

Parvin, Salma, et al. "LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL." Cancer Cell 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.